Supplemental material
Journal of Biological Dynamics
Volume 16, 2022 - Issue 1
Research Article
Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework
Dimitrios Voulgarelisa DMPK Oncology R&D, AstraZeneca, Cambridge, UK;b Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK;c AstraZeneca Postdoc Programme, Cambridge, UKCorrespondence[email protected]
https://orcid.org/0000-0001-8857-7899View further author information
https://orcid.org/0000-0001-8857-7899View further author information, Krishna C. Bulusub Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UKhttps://orcid.org/0000-0002-5092-6640View further author information
https://orcid.org/0000-0002-5092-6640View further author information & Related Research Data
Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework
Source:
Taylor & Francis
Linking provided by
